HOWELL; Stephen B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HOWELL; Stephen B..The latest application filed is for "cell-targeted cytotoxic constructs".

Company Profile

0.9.4

HOWELL; Stephen B. - La Jolla CA
Howell; Stephen B. - Del Mar CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cell-targeted Cytotoxic Constructs App 20220267752 - LIN; Xinjian ; et al.	2022-08-25
Cell-targeted cytotoxic constructs Grant 11,193,117 - Lin , et al. December 7, 2	2021-12-07
Sortase-modified Molecules And Uses Thereof App 20170260517 - LIN; Xinjian ; et al.	2017-09-14
Molecular markers of cisplatin resistance in cancer and uses thereof App 20060019268 - Cheng; Timothy C. ; et al.	2006-01-26
Quantification Of Cellular Injury Using Expression Of A Fluorescent Protein Under The Control Of The Gadd153 Promoter App 20010007768 - HOWELL, STEPHEN B. ; et al.	2001-07-12
Multivesicular liposomes with controlled release of active agents encapsulated in the presence of a hydrochloride Grant 6,071,534 - Kim , et al. June 6, 2	2000-06-06
Combination platinum chemotherapeutic/antiestrogen therapy for human cancers Grant 5,844,001 - McClay , et al. December 1, 1	1998-12-01
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride Grant 5,807,572 - Kim , et al. September 15, 1	1998-09-15
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride Grant 5,723,147 - Kim , et al. March 3, 1	1998-03-03
Method for treating neurological disorders Grant 5,576,018 - Kim , et al. November 19, 1	1996-11-19
Method for treating neurological disorders Grant 5,455,044 - Kim , et al. October 3, 1	1995-10-03
Diagnostic assay based on cis-plain drug resistance gene Grant 5,434,046 - Enns , et al. July 18, 1	1995-07-18
Enhancement of anti-neoplastic drug efficacy using EGF Grant 5,252,342 - Howell , et al. October 12, 1	1993-10-12

Company Registrations

SEC

0001464306

Howell Stephen B.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.